Skip to Main Content
MENU
Careers

We’re always seeking talented people who share our vision. Click here to explore opportunities in a variety of disciplines across the globe.

See More >
Leadership Blogs

Get to know our leaders. Read their unique perspectives on how they are working to change the trajectory of health.

See More >
Generation Care™

We’re committed to showing the heart of the caregiver’s experience and providing the kind of support and information that will make a difference.

See More >
Patient Engagement

Janssen partners directly with patients and caregivers as we develop medicines, improve clinical trials, and create educational materials and support programs.

See More >
Research & Development

Our research pipeline is rich with transformational science reflecting our unique approach to innovation.

See More >
R&D Data Science

Using data science and digital health to reimagine the discovery and development of medicines to advance our mission of bringing transformative therapies to patients.

See More >
  • A little boy is carried on the shoulders of a man
    A little boy is carried on the shoulders of a manA little boy is carried on the shoulders of a man

    Fearlessly
    Taking on
    Diabetic Eye
    Disease

Item 1 of 1

~21 million people

worldwide have diabetic macular edema (DME)1

191 million people

worldwide are estimated to have diabetic retinopathy (DR) by 20302

A woman kisses the forehead of a young boy with their eyes closed

Diabetes is a chronic disease that can lead to vision loss and blindness3

In people living with diabetes, DR occurs when too much sugar in the blood causes damage to the blood vessels, leading to a leakage of fluid in the retina.4

This fluid can cause swelling in the central part (macula) of the eye, known as edema. This serious eye complication is called DME.5

Janssen is investigating therapeutic innovations that aim to improve the lives of patients with diabetic eye disease, such as DME and DR, which are the leading causes of vision loss globally.6,7

“

Leveraging Janssen's expertise and legacy in pioneering innovative therapies, we strive to change the lives of those impacted by retinal diseases.

-Eddy Anglade, MD – Vice President and Clinical Lead, Retina – Janssen Research and Development, LLC

”

See our investments and advancements in treatments for diabetic eye disease

View our research
A scientist wearing goggles and a mask works in a lab
Hide referencescollapse

  1. Zhang X, Zeng H, Bao S, Wang N, Gillies MC. Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci. 2014;4(27):1-14.

  2. Pescosolido N, Buomprisco G. Psychophysical exams as early indicators of diabetic retinopathy. Eur Endocrinol. 2014;10(1):61-65.

  3. Global report on diabetes. World Health Organization. Published April 21, 2016. Accessed August 24, 2021. https://www.who.int/publications/i/item/9789241565257

  4. Diabetic retinopathy. Mayo Clinic. Accessed September 29, 2021. https://www.mayoclinic.org/diseases-conditions/diabetic-retinopathy/symptoms-causes/syc-20371611

  5. Diabetic macular edema. Mayo Clinic. Accessed September 29, 2021. https://www.mayoclinic.org/diseases-conditions/diabetic-retinopathy/multimedia/diabetic-macular-edema/img-20124558

  6. Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):e1221-e1234.

  7. Flaxman SR, Bourne RRA, Resnikoff S, et al. Supplementary appendix. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12)(suppl):S1-S75.